GKB (1707.TW) monthly revenue, September 2026
GKB reported revenue of NT$0.73bn for September 2026, up 2.9% from the previous month and down 7.9% from a year earlier. Year-to-date revenue was NT$6.84bn, down 5.6% year on year. It ranked 121 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.73 | 2.9 | -7.9 |